Detail akcie Baxter Intl online

Business Summary: Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Baxter International Inc revenues increased 2% to $14.81B. Net loss before extraordinary items decreased 97% to $76M. Revenues reflect Medical Products and Therapies segment increase of 4% to $5.01B, Pharmaceuticals segment increase of 6% to $2.25B, Healthcare Systems and Technologies segment increase of 3% to $3.01B, United States segment increase of 10% to $7.64B.